Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Amicus Therapeutics, Inc.
Amicus Therapeutics Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of next-generation medicines.
IPO Date: May 31, 2007
Sector: Healthcare
Industry: Biotech
Market Cap: $2.46B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.23 | 2.67%
Avg Daily Range (30 D): $0.13 | 1.94%
Avg Daily Range (90 D): $0.13 | 2.02%
Institutional Daily Volume
Avg Daily Volume: 1.51M
Avg Daily Volume (30 D): 3.61M
Avg Daily Volume (90 D): 3.99M
Trade Size
Avg Trade Size (Sh.): 147
Avg Trade Size (Sh.) (30 D): 158
Avg Trade Size (Sh.) (90 D): 161
Institutional Trades
Total Inst.Trades: 7,354
Avg Inst. Trade: $2.9M
Avg Inst. Trade (30 D): $2.63M
Avg Inst. Trade (90 D): $3.1M
Avg Inst. Trade Volume: .26M
Avg Inst. Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $3.58M
Avg Closing Trade (30 D): $4.1M
Avg Closing Trade (90 D): $4.24M
Avg Closing Volume: 324.07K
   
News
Aug 29, 2025 @ 11:00 AM
Amicus Therapeutics to Present at Upcoming Investo...
Source: Amicus Therapeutics
Aug 6, 2025 @ 12:30 PM
Clinical Progress in Rare Disease Signals Long-Ter...
Source: Prnewswire
Jul 31, 2025 @ 11:00 AM
Amicus Therapeutics Announces Second Quarter 2025 ...
Source: Amicus Therapeutics
Jun 3, 2025 @ 11:00 AM
New Analysis of Pombiliti® (cipaglucosidase alf...
Source: Amicus Therapeutics
May 30, 2025 @ 11:00 AM
Amicus Therapeutics to Present at Upcoming Investo...
Source: N/A
Financials
  TTM Q2 2025 Q1 2025
Basic EPS $-.08 $-.07
Diluted EPS $-.08 $-.07
Revenue $ $ 154.69M $ 125.25M
Gross Profit $ $ 139.47M $ 113.55M
Net Income / Loss $ $ -24.42M $ -21.69M
Operating Income / Loss $ $ -9.47M $ -7.95M
Cost of Revenue $ $ 15.22M $ 11.7M
Net Cash Flow $ $ -22.72M $ -31.98M
PE Ratio